Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients
- PMID: 18803358
- PMCID: PMC2744168
- DOI: 10.3748/wjg.14.5448
Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients
Abstract
Aim: To characterize the clinical, serologic and virologic features of hepatitis B virus (HBV) infection in Iranian patients with different stages of liver disease.
Methods: Sixty two patients comprising of 12 inactive carriers, 30 chronic hepatitis patients, 13 patients with liver cirrhosis and 7 patients with hepatocellular carcinoma (HCC) were enrolled in the study. The HBV S, C and basal core promoter (BCP) regions were amplified and sequenced, and the clinical, serologic, phylogenetic and virologic characteristics were investigated.
Results: The study group consisted of 16 HBeAg-positive and 46 HBeAg-negative patients. Anti-HBe-positive patients were older and had higher levels of ALT, ASL and bilirubin compared to HBeAg-positive patients. Phylogenetic analysis revealed that all patients were infected with genotype D (mostly ayw2). The G1896A precore (PC) mutant was detected in 58.1% patients. HBeAg-negative patients showed a higher rate of PC mutant compared to HBeAg-positive patients (c2 = 9.682, P = 0.003). The majority of patients with HCC were HBeAg-negative and were infected with PC mutant variants. There was no significant difference in the occurrence of BCP mutation between the two groups, while the rate of BCP plus PC mutants was higher in HBeAg-negative patients (c2 = 4.308, P = 0.04). In the HBV S region, the genetic variability was low, and the marked substitution was P120T/S, with a rate of 9.7% (n = 6).
Conclusion: In conclusion, HBV/D is the predominant genotype in Iran, and the nucleotide variability in the BCP and PC regions may play a role in HBV disease outcome in HBeAg-negative patients.
Figures

Similar articles
-
Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.World J Gastroenterol. 2015 Jun 7;21(21):6639-48. doi: 10.3748/wjg.v21.i21.6639. World J Gastroenterol. 2015. PMID: 26074702 Free PMC article.
-
Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.Infect Genet Evol. 2013 Dec;20:103-10. doi: 10.1016/j.meegid.2013.08.013. Epub 2013 Aug 23. Infect Genet Evol. 2013. PMID: 23978387
-
Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.BMC Gastroenterol. 2006 Jul 24;6:20. doi: 10.1186/1471-230X-6-20. BMC Gastroenterol. 2006. PMID: 16863587 Free PMC article.
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.World J Gastroenterol. 2014 Jun 28;20(24):7644-52. doi: 10.3748/wjg.v20.i24.7644. World J Gastroenterol. 2014. PMID: 24976702 Free PMC article. Review.
Cited by
-
Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features.Jundishapur J Microbiol. 2015 Sep 12;8(9):e20262. doi: 10.5812/jjm.20262. eCollection 2015 Sep. Jundishapur J Microbiol. 2015. PMID: 26487918 Free PMC article.
-
Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran.Hepat Mon. 2013 May 29;13(5):e10134. doi: 10.5812/hepatmon.10134. eCollection 2013 May. Hepat Mon. 2013. PMID: 23967017 Free PMC article.
-
Hepatitis B virus genotyping among chronic hepatitis B individuals with resistance to Lamivudine in shahrekord, iran.Jundishapur J Microbiol. 2014 Apr;7(4):e10196. doi: 10.5812/jjm.10196. Epub 2014 Apr 1. Jundishapur J Microbiol. 2014. PMID: 25147693 Free PMC article.
-
Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections.Hepat Mon. 2016 May 3;16(5):e34790. doi: 10.5812/hepatmon.34790. eCollection 2016 May. Hepat Mon. 2016. PMID: 27330536 Free PMC article.
-
Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?Hepat Mon. 2012 Oct;12(10 HCC):e7879. doi: 10.5812/hepatmon.7879. Epub 2012 Oct 30. Hepat Mon. 2012. PMID: 23233866 Free PMC article.
References
-
- Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395–403. - PubMed
-
- Hannoun C, Horal P, Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol. 2000;81:75–83. - PubMed
-
- Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002;83:1267–1280. - PubMed
-
- Tacke F, Manns MP, Trautwein C. Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies. Curr Med Chem. 2004;11:2667–2677. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous